Table 2 Relative 5-year survival of breast cancer patients by age group, TNM stage, histology, grade and treatment from univariate analysis, ORCC, 1994–1997

From: Survival of women with breast cancer in Ottawa, Canada: variation with age, stage, histology, grade and treatment

 

No. (%)a

Relative survival (%)

Prognostic factor

observations

Rate

95% CIb

Age at diagnosis (years)

   

 0–39

147 (6.7)

69.9

60.5–77.5

 40–49

448 (20.4)

84.2

79.3–88.1

 50–69

972 (44.3)

88.4

84.9–91.4

 70+

625 (28.5)

81.3

74.9–86.2

TNM stage c

   

 Stage I

812 (37.0)

96.0

92.7–97.8

 Stage II

843 (38.5)

85.6

81.7–88.7

 Stage III

155 (7.1)

59.2

47.9–68.9

 Stage IV

112 (5.1)

25.5

16.1–36.0

Histology type

   

 Ductal carcinoma

1765 (80.5)

84.32

81.6–86.7

 Lobular carcinoma

233 (10.6)

91.02

81.0–95.9

 Others

194 (8.9)

76.65

67.7–83.4

Histologic grade c

   

 G1 (well differentiated)

346 (15.8)

97.2

90.9–99.1

 G2 (moderately differentiated)

674 (30.8)

87.8

83.7–91.0

 G3 (poorly differentiated)

474 (21.6)

73.9

68.0–78.9

Treatment c

   

 Chemotherapy

38 (1.7)

46.2

25.2–64.8

 Radiotherapy

54 (2.5)

87.7

73.1–94.7

 Surgery

188 (8.6)

89.1

77.2–94.9

 Chemotherapy+radiotherapy

135 (6.2)

61.4

51.3–70.1

 Chemotherapy+surgery

396 (18.1)

82.1

75.8–86.9

 Radiotherapy+surgery

389 (17.8)

96.0

89.7–98.6

 Chemotherapy+radiotherapy+surgery

972 (44.3)

77.4

73.3–80.9

  1. aP-value of χ2 test for the changes in a variable structure was less than 0.0001 for each variable considered.
  2. bCI=confidence interval.
  3. cUnstaged (%)=12.3, ungraded=31.8 and untreated or unknown=0.9.